Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 178 articles:
HTML format



Single Articles


    December 2021
  1. MOLLY S, Margaret M, Erin F
    P076 The Role of Dual Biologic Therapy in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021;116.
    PubMed    


  2. JARED S, Edward B, Xian Z, Millie L, et al
    P075 Urgency and its Association with Quality of Life and Clinical Outcomes in Ulcerative Colitis Patients.
    Am J Gastroenterol. 2021;116.
    PubMed    


  3. RAHUL D, Jennifer M, Hannah G, Jessica A, et al
    P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naive Patients With Ulcerative Colitis.
    Am J Gastroenterol. 2021;116.
    PubMed    


  4. BENJAMIN S, Kristine P, Kevin T, James M, et al
    P072 Non-invasive Vagal Nerve Stimulation to Treat Crohn Disease and Ulcerative Colitis in Children and Young Adults: A Proof-of-Concept Clinical Trial.
    Am J Gastroenterol. 2021;116.
    PubMed    


  5. JOSE RL, Jesus LG, Tomas CE, Korely TF, et al
    P063 Prevalence in the Use of Complementary/Alternative Medicine in Patients With Inflammatory Bowel Disease from Centro Medico Nacional 20 de Noviembre.
    Am J Gastroenterol. 2021;116.
    PubMed    


  6. KORELY TF, Jesus LG, Tomas CE, Rebeca PC, et al
    P061 Impact of Inflammatory Bowel Disease on sleep quality in a Mexican population attended in a referral center.
    Am J Gastroenterol. 2021;116.
    PubMed    


  7. VIVIANA PI, Jaiber G, Cristian F, Diego J, et al
    P060 Screening Criteria of Inflammatory Bowel Disease: Application in Colombian Patients With Spondyloarthritis.
    Am J Gastroenterol. 2021;116.
    PubMed    


  8. JULTON TC, Lauren S, Mouhammed S, Adil M, et al
    P058 Impact of Inflammatory Bowel Disease Treatment and Risk of Covid-19 Infection after Full Immunization: A Nationwide Analysis.
    Am J Gastroenterol. 2021;116.
    PubMed    


  9. CARLOS PA, Tomas CE, Jesus LG, Korely TF, et al
    P057 How Distance Between Residence and Treatment Center Impact the Outcome of Patients With Inflammatory Bowel Disease at CMN 20.
    Am J Gastroenterol. 2021;116.
    PubMed    


  10. VIVIANA PI, Juan FO, Pablo G, Consuelo RS, et al
    P056 Real life experience with the use of tofacitinib in ulcerative colitis in Colombia: case series.
    Am J Gastroenterol. 2021;116.
    PubMed    


  11. SANG TC, Sarah A, Yousef E, Joshua T, et al
    P055 Sociodemographic Differences in Fecal Enteropathogen Testing Patterns in Adults Hospitalized for Inflammatory Bowel Disease Flares.
    Am J Gastroenterol. 2021;116.
    PubMed    


  12. MIKAELL F, Ligia S, Adriana A, Roberto KJ, et al
    P052 National Registration of Patients With Inflammatory Bowel Disease in Brazil on Behalf of GEDIIB.
    Am J Gastroenterol. 2021;116.
    PubMed    


  13. MARTA F, Tiago LC, Vitor MS, Catia A, et al
    P051 Identifying High-Risk Patients With Acute Severe Ulcerative Colitis: Is the ACE Index Useful?
    Am J Gastroenterol. 2021;116.
    PubMed    


  14. VIVIANA PI, Katherin C, Julio A, Maria B, et al
    P050 Oral Inflammatory Changes Associated With Inflammatory Bowel Disease in Spondyloarthritis Associated With Early Endoscopic Findings.
    Am J Gastroenterol. 2021;116.
    PubMed    


  15. DANIEL S, Marina L, Ana Carolina O, Rodrigo B, et al
    P049 Investigation of Liver Diseases by Ultrasound in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021;116.
    PubMed    


  16. MARINA L, Daniel S, Ana Carolina O, Rodrigo B, et al
    P045 Prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with inflammatory bowel disease (IBD) in a Brazilian public healthcare clinic.
    Am J Gastroenterol. 2021;116.
    PubMed    


  17. QIAN C, Myrlene S, Nurgul B, Lilla DS, et al
    P043 Resource Utilization and Productivity Loss among Patients with Inflammatory Bowel Disease in Sweden: A Longitudinal Nationwide Population-based Study.
    Am J Gastroenterol. 2021;116.
    PubMed    


  18. MILLIE L, Raymond C, Jonathan C, Marc P, et al
    P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis.
    Am J Gastroenterol. 2021;116.
    PubMed    


  19. JEAN-FREDERIC C, Geert D, Peter I, AnnKatrin P, et al
    P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 Trial.
    Am J Gastroenterol. 2021;116.
    PubMed    


  20. DAVID H, Millie L, Douglas W, Stephen H, et al
    P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study.
    Am J Gastroenterol. 2021;116.
    PubMed    


  21. BRUCE S, Marc P, Michael S, AnnKatrin P, et al
    P031 Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North Study.
    Am J Gastroenterol. 2021;116.
    PubMed    


  22. DAVID R, Remo P, Alison PB, Cem K, et al
    P028 Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Patient and Healthcare Professional Perspectives on Experience of Ulcerative Colitis Symptoms.
    Am J Gastroenterol. 2021;116.
    PubMed    


  23. APAAR D, Khushboo G, Jayesh R, Shesh R, et al
    P027 Brain Fog in Patients With Inflammatory Bowel Disease, and Association With Use of Probiotics.
    Am J Gastroenterol. 2021;116.
    PubMed    


  24. ADAM S, Nicole L, Heba I, Harini N, et al
    P026 Inflammatory Bowel Disease (IBD) Related Outcomes in Patients Diagnosed With COVID-19.
    Am J Gastroenterol. 2021;116.
    PubMed    


  25. SIGRID Y, Scott S, Shannon C
    P024 Anorectal Manometry in Patients with Fecal Incontinence After Ileal Pouch-Anal Anastomosis for Inflammatory Bowel Disease: A Cohort Study.
    Am J Gastroenterol. 2021;116.
    PubMed    


  26. KEVIN C, Sandra K, Noll R
    P023 Parental Distress in Pediatric Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021;116.
    PubMed    


  27. VARUN J, Brian B, Esteban F
    P022 Biologic Therapy and Therapeutic Drug Monitoring in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2021;116.
    PubMed    


  28. VITOR MS, Tiago LC, Marta F, Tiago CG, et al
    P020 Proton Pump Inhibitor Therapy: Providing "Acid" Outcomes in Patients With Inflammatory Bowel Disease Under Infliximab Treatment.
    Am J Gastroenterol. 2021;116.
    PubMed    


  29. IANA G, Randall J, Marc P
    P019 Not All Fecal Calprotectin is Specific for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021;116.
    PubMed    


  30. MARIYA Z, Oleg K, Karina N
    P017 Increased Level of Immunoglobulin G in the Development of Adverse Reactions in Patients With Ulcerative Colitis.
    Am J Gastroenterol. 2021;116.
    PubMed    


  31. RICHARD WY
    P011 Prevalence of Cannabis Use Disorder in Inflammatory Bowel Disease Hospitalizations in the United States and Effect on Length of Stay.
    Am J Gastroenterol. 2021;116.
    PubMed    


  32. HARTMAN B, Diana H, Casey C
    P009 Assessing the Status Quo: Ulcerative Colitis Monitoring in a Community GI Practice.
    Am J Gastroenterol. 2021;116.
    PubMed    


  33. OLEG K, Sergey K, Anna K, Albina L, et al
    P006 The Relationship of Histological Remission With the Duration of the Anamnesis Ulcerative Colitis.
    Am J Gastroenterol. 2021;116.
    PubMed    


  34. OLEG K, Anna K, Albina L, Anait B, et al
    P004 Steroid-Free Remission in Patients With Ulcerative Colitis Receiving Tofacitinib in Real Clinical Practice.
    Am J Gastroenterol. 2021;116.
    PubMed    


  35. HUI C, Tian F, Lintao D, Xuejie C, et al
    P003 Meat Consumption and All-Cause Mortality in 5763 Inflammatory Bowel Disease Patients: A Prospective Cohort Study.
    Am J Gastroenterol. 2021;116.
    PubMed    


    November 2021
  36. MELMED GY, Oliver B, Hou JK, Lum D, et al
    Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 Nov 19. pii: 00000434-990000000-00153.
    PubMed     Abstract available


  37. CALDERA F, Knutson KL, Saha S, Wald A, et al
    Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls.
    Am J Gastroenterol. 2021 Nov 18. pii: 00000434-990000000-00148.
    PubMed     Abstract available


  38. BRUNT H, Chapman JC
    The Inflammatory Bowel Disease-Focused Primary Care Provider: An Addition to the IBD Specialty Medical Home.
    Am J Gastroenterol. 2021 Nov 17. pii: 00000434-990000000-00144.
    PubMed    


  39. NGUYEN NH, Martinez I, Atreja A, Sitapati AM, et al
    Digital Health Technologies for Remote Monitoring and Management of Inflammatory Bowel Disease: A Systematic Review.
    Am J Gastroenterol. 2021 Nov 9. pii: 00000434-990000000-00141.
    PubMed     Abstract available


  40. ALMARIO CV, Kogan L, van Deen WK, Scott FI, et al
    Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 Nov 3. pii: 00000434-990000000-00133.
    PubMed     Abstract available


  41. CHO JM, Loftus EV Jr, Bruining DH, Chedid VG, et al
    Vulvar Crohn's Disease: Clinical Features and Outcomes.
    Am J Gastroenterol. 2021;116:2296-2299.
    PubMed     Abstract available


    October 2021
  42. LAUBE R, Tran Y, Paramsothy S, Leong RW, et al
    Assisted Reproductive Technology in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2021 Oct 25. pii: 00000434-990000000-00131.
    PubMed     Abstract available


  43. THAKUR K, Barrett TA
    Social Determinants of Health in Inflammatory Bowel Diseases: Barriers and Opportunities.
    Am J Gastroenterol. 2021;116:2146.
    PubMed    


  44. ASHHAB AA, Lee M, Melmed GY
    Extensive Upper Gastrointestinal Fistulization in Crohn's Disease, an Uncommon Cause for a Common Presentation.
    Am J Gastroenterol. 2021;116:1978.
    PubMed    


    September 2021
  45. BATTAT R, Long MD
    Is Proactive Therapeutic Drug Monitoring Ready for the Spotlight in Inflammatory Bowel Disease? Follow the Data.
    Am J Gastroenterol. 2021 Sep 13. pii: 00000434-990000000-00100.
    PubMed     Abstract available


    August 2021
  46. SANGHA M, Roitman I, Sultan K, Swaminath A, et al
    SARS-CoV-2 Immunization in Patients With Inflammatory Bowel Disease May Result in Disease Flares.
    Am J Gastroenterol. 2021 Aug 18. pii: 00000434-990000000-00081.
    PubMed    


  47. CHEIFETZ AS, Abreu MT, Afif W, Cross RK, et al
    A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 Aug 13. pii: 00000434-990000000-00067.
    PubMed     Abstract available


  48. RICCIUTO A, Carman N, Benchimol EI, Siddiqui I, et al
    Prospective Evaluation of Endoscopic and Histologic Indices in Pediatric Ulcerative Colitis Using Centralized Review.
    Am J Gastroenterol. 2021 Aug 13. pii: 00000434-990000000-00066.
    PubMed     Abstract available


  49. DULAI PS, Jairath V, Narula N, Wong E, et al
    A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's Disease.
    Am J Gastroenterol. 2021;116:1709-1719.
    PubMed     Abstract available


    July 2021
  50. HARRISON N, Humes R, Singla M
    Skip, Stop, Switch, and Spare: Steroid Therapy in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00049.
    PubMed    


  51. SCHUMANN M, Sonnenberg E, Siegmund B, Meier K, et al
    A 39-Year-Old Man With Crohn's Disease and a Unclear Rash on His Left Cheek.
    Am J Gastroenterol. 2021;116:1374.
    PubMed    


    June 2021
  52. ABDALLA MI, Levesque BG
    Progress in Corticosteroid Use in the Era of Biologics With Room for Improvement.
    Am J Gastroenterol. 2021;116:1187-1188.
    PubMed     Abstract available


  53. TARGOWNIK LE, Bernstein CN, Benchimol EI, Kaplan GG, et al
    Trends in Corticosteroid Use During the Era of Biologic Therapy: A Population-Based Analysis.
    Am J Gastroenterol. 2021;116:1284-1293.
    PubMed     Abstract available


    May 2021
  54. DE GIORGI V, Trane L, Silvestri F, Venturi F, et al
    Pyodermatitis-Pyostomatitis Vegetans in Active Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 May 31. pii: 00000434-900000000-98762.
    PubMed    


  55. BOTWIN GJ, Li D, Figueiredo J, Cheng S, et al
    Adverse Events Following SARS-CoV-2 mRNA Vaccination: Among Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 May 25. pii: 00000434-900000000-98766.
    PubMed     Abstract available


  56. TEICH N, Stallmach A, Bruns T
    Greenspace in Childhood: A New Avenue to Prevent Inflammatory Bowel Disease?
    Am J Gastroenterol. 2021 May 7. pii: 00000434-900000000-98784.
    PubMed    


  57. TANG J, Huang Z, Guo H, Ding N, et al
    Online Video Clinic Satisfies the Medical Requirements of Patients with IBD During the COVID-19 Outbreak.
    Am J Gastroenterol. 2021;116:1087.
    PubMed    


  58. PAPAMICHAEL K, Vande Casteele N, Jeyarajah J, Jairath V, et al
    Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis.
    Am J Gastroenterol. 2021;116:1007-1014.
    PubMed     Abstract available


    April 2021
  59. KHAN N, Patel D, Xie D, Pernes T, et al
    Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study.
    Am J Gastroenterol. 2021;116:808-810.
    PubMed     Abstract available


  60. KHAN N, Patel D, Trivedi C, Kavani H, et al
    Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
    Am J Gastroenterol. 2021;116:741-747.
    PubMed     Abstract available


  61. SONNENBERG A
    Do Forgotten Symptoms Need Treatment?
    Am J Gastroenterol. 2021;116:841-842.
    PubMed    


  62. HA C
    The Age-Old Conundrum With Thiopurines: Are the Accumulating Risks Greater Than Benefits?
    Am J Gastroenterol. 2021;116:671-672.
    PubMed     Abstract available


    March 2021
  63. BERNSTEIN CN, Nugent Z, Singh H
    Persistently High Rate of Venous Thromboembolic Disease in Inflammatory Bowel Disease: A Population-Based Study.
    Am J Gastroenterol. 2021 Mar 24. pii: 00000434-900000000-98845.
    PubMed     Abstract available


  64. SLATER NR, Loomes DE
    Endoscopic Vacuum-Assisted Wound Closure of a Rectal Perforation in the Setting of Active Ulcerative Colitis.
    Am J Gastroenterol. 2021 Mar 2. pii: 00000434-900000000-98819.
    PubMed    


    January 2021
  65. COELHO-PRABHU N, Kane S
    Does Size Really Matter?
    Am J Gastroenterol. 2021;116:84-85.
    PubMed     Abstract available


  66. HAMMOUDI N, Allez M
    Response to Hanzel.
    Am J Gastroenterol. 2021;116:218.
    PubMed    


  67. HANZEL J
    A Novel Endoscopic Score for Postoperative Recurrence of Crohn's Disease: More Information Needed.
    Am J Gastroenterol. 2021;116:217-218.
    PubMed    


  68. RIVIERE P, D'Haens G, Peyrin-Biroulet L, Baert F, et al
    Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.
    Am J Gastroenterol. 2021;116:134-141.
    PubMed     Abstract available


    December 2020
  69. LACY BE, Pimentel M, Brenner DM, Chey WD, et al
    ACG Clinical Guideline: Management of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Dec 14. doi: 10.14309/ajg.0000000000001036.
    PubMed     Abstract available


  70. KORELITZ BI, Sachar DB, Schneider J
    Full Potential of 6-Mercaptopurine in IBD May Remain Untapped.
    Am J Gastroenterol. 2020;115:2109-2110.
    PubMed    


  71. FERNANDA F, Mirella O, Danielle F, Pedro G, et al
    P074 Prevalence and Associated Factors With Non-Adherence to Maintenance Therapy for Ulcerative Colitis in Deep Remission.
    Am J Gastroenterol. 2020;115.
    PubMed    


  72. PRADEEP KR, Deloshaan S, Dheeraj S, Hadi M, et al
    P070 Outcomes of Acute Severe Ulcerative Colitis in Older Adults.
    Am J Gastroenterol. 2020;115.
    PubMed    


  73. DELOSHAAN S, Pradeep KR, Dheeraj S, Hadi M, et al
    P069 Admission Steroid Use, Serum Albumin and Endoscopic Severity Predict Intravenous Steroid Failure in Patients With Acute Severe Ulcerative Colitis.
    Am J Gastroenterol. 2020;115.
    PubMed    


  74. JAQUELINE B, Juliana C, Dos Santos B, Caroline D, et al
    P068 Therapeutic Aspects in Pediatric Inflammatory Bowel Disease - A Multi-Centric Study From Brazil.
    Am J Gastroenterol. 2020;115.
    PubMed    


  75. FLAVIA P, Cyrla Z, de Souza H, Jessica M, et al
    P066 Hospitalization and Surgery Rates in Patients With Inflammatory Bowel Disease in Brazil: A Time-Trend Analysis.
    Am J Gastroenterol. 2020;115.
    PubMed    


  76. JENNIFER MO, Megan L, Jean A
    P065 Inflammatory Bowel Disease or Bowel Endometriosis? Two Cases of Large Bowel Obstruction.
    Am J Gastroenterol. 2020;115.
    PubMed    


  77. JAQUELINE B, Juliana C, Dos Santos Beatriz, Caroline D, et al
    P064 Clinical Aspects of Pediatric Inflammatory Bowel Disease - A Multicentric Study From Brazil.
    Am J Gastroenterol. 2020;115.
    PubMed    


  78. FABIANA B, Cesar A, Marcio C, Carolina M, et al
    P061 Prophylaxis of Hepatitis B Reactivation and Inflammatory Bowel Disease: A case report.
    Am J Gastroenterol. 2020;115.
    PubMed    


  79. SVETLANA L, Morris G, Vasiliki S
    P056 Power Calculations in Randomised Controlled Trials of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020;115.
    PubMed    


  80. WALAA M, Hisham W, Walid H, Fadi F, et al
    P049 Should the Gallbladder be Empirically Removed at Time of Intestinal Resection in Inflammatory Bowel Disease Patients?
    Am J Gastroenterol. 2020;115.
    PubMed    


  81. ERIC J
    P047 Awareness and Impact of Recent AGA Guideline Changes for Moderate to Severe Ulcerative Colitis Patients.
    Am J Gastroenterol. 2020;115.
    PubMed    


  82. ERIC J
    P046 Though Biosimilar Infliximab Prescribing in Inflammatory Bowel Disease Has Increased, Branded Infliximab Continues to Be Prescribed More Often.
    Am J Gastroenterol. 2020;115.
    PubMed    


  83. CASEY C, Jenny G, Michelle B, Joe L, et al
    P042 The CONCERT Initiative: Impact of Inflammatory Bowel Disease Care Referral Pathway.
    Am J Gastroenterol. 2020;115.
    PubMed    


  84. SARA L, Millie L, Uma M
    P040 Indications for Cesarean Section in Pregnant Women with Inflammatory Bowel Disease: Results from the PIANO Registry.
    Am J Gastroenterol. 2020;115.
    PubMed    


  85. SARA H, David H, Joe Z, Ryan H, et al
    P038 Factors Associated with Impaired Patient-Reported Outcomes and Work Productivity Among Patients with Ulcerative Colitis in Remission.
    Am J Gastroenterol. 2020;115.
    PubMed    


  86. DAVID P, Caterina O, Christopher A, Gregory AC, et al
    P037 Efficacy and Safety of 1-L NER1006 Bowel Preparation in Patients with Inflammatory Bowel Disease: Analysis of 2 Phase 3 Studies.
    Am J Gastroenterol. 2020;115.
    PubMed    


  87. CLARA U, Amanda T, Debora T, Giovana C, et al
    P036 Clinical and Psychological Factors Associated with Impaired Body Image in Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020;115.
    PubMed    


  88. KAUSTAV S, Austin T, Roman G, Allison M, et al
    P033 Demographic Factors Associated with Successful Telehealth Visits in Inflammatory Bowel Disease Patients.
    Am J Gastroenterol. 2020;115.
    PubMed    


  89. WILLIAM S, Brian F, Stephen H, Severine V, et al
    P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension.
    Am J Gastroenterol. 2020;115.
    PubMed    


  90. SILVIO D, Brian F, Stephen H, Igor J, et al
    P030 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Maintenance in the Phase 3 True North Study.
    Am J Gastroenterol. 2020;115.
    PubMed    


  91. EDWARD B, Harris A, Joe Z, Antoine S, et al
    P027 Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD.
    Am J Gastroenterol. 2020;115.
    PubMed    


  92. SHINTARO A, Jacob O, Cindy T, Victoria R, et al
    P026 Assessment of Contributing Factors for Fistula Development in Patients with Inflammatory Bowel Disease Treated by Proctocolectomy with Ileal Pouch-Anal Anastomosis.
    Am J Gastroenterol. 2020;115.
    PubMed    


  93. WILLIAM S, Geert D, Doug W, Stephen H, et al
    P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study.
    Am J Gastroenterol. 2020;115.
    PubMed    


  94. GALIYA B, Alisa R, Maria L
    P024 Medical Decision Support System in the Diagnosis of Ulcerative Colitis.
    Am J Gastroenterol. 2020;115.
    PubMed    


  95. MICHAEL C, Puza S, Benjamin C, Leonardo S, et al
    P021 Characteristics of Patients Treated with Tofacitinib for Ulcerative Colitis in the Real World: Findings from a Large US Claims Database.
    Am J Gastroenterol. 2020;115.
    PubMed    


  96. SUBRATA G, Geert D, Vipul J, Florian R, et al
    P012 Ozanimod Reduced Fecal Calprotectin Levels in Patients with Ulcerative Colitis in the Phase 3 True North Study.
    Am J Gastroenterol. 2020;115.
    PubMed    


  97. ROGERIO P, Julio C, Liliana C, Erika B, et al
    P008 Long-Term Effectiveness and Safety of Ustekinumab for The Treatment of Crohn s Disease: A Brazilian Multicentre Real-world Study.
    Am J Gastroenterol. 2020;115.
    PubMed    


  98. OLEG K, Albina L, Anatoliy K, Anna K, et al
    P005 Overcoming Secondary Loss of Response to Infliximab in Patients With Ulcerative Colitis With the Use of Mesenchymal Stromal Cells.
    Am J Gastroenterol. 2020;115.
    PubMed    


  99. OLEG K, Anna K, Albina L, Tatyana S, et al
    P002 Frequency and Causes of Prolongation of the Induction Course of Tofacitinib in Patients with Ulcerative Colitis.
    Am J Gastroenterol. 2020;115.
    PubMed    


  100. ERNESTO R, Rachel H, Meera L, Pablo P, et al
    P001 North-South Gradient in the Incidence of Pediatric Inflammatory Bowel Disease Along the Atlantic Coast.
    Am J Gastroenterol. 2020;115.
    PubMed    


    November 2020
  101. KHAN N, Patel D, Trivedi C, Kavani H, et al
    Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
    Am J Gastroenterol. 2020 Nov 26. doi: 10.14309/ajg.0000000000001058.
    PubMed     Abstract available


  102. ZAVER HB, Ghoz H, Azar A, Alexander LF, et al
    Inferior Mesenteric Arteriovenous Malformation Masquerading as Ulcerative Colitis.
    Am J Gastroenterol. 2020 Nov 10. doi: 10.14309/ajg.0000000000000917.
    PubMed    


  103. CHAPARRO M, Gordillo J, Domenech E, Esteve M, et al
    Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Am J Gastroenterol. 2020;115:1802-1811.
    PubMed     Abstract available


  104. BANTY A, Melmed GY
    Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection?
    Am J Gastroenterol. 2020;115:1797-1798.
    PubMed     Abstract available


  105. LITTLE DHW, Tabatabavakili S, Shaffer SR, Nguyen GC, et al
    Effectiveness of Dose De-escalation of Biologic Therapy in Inflammatory Bowel Disease: A Systematic Review.
    Am J Gastroenterol. 2020;115:1768-1774.
    PubMed     Abstract available


  106. WINDSOR JW, Underwood FE, Brenner E, Colombel JF, et al
    Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD Registry.
    Am J Gastroenterol. 2020;115:1923-1924.
    PubMed    


  107. CHAPUIS-BIRON C, Kirchgesner J, Pariente B, Bouhnik Y, et al
    Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID.
    Am J Gastroenterol. 2020;115:1812-1820.
    PubMed     Abstract available


    October 2020
  108. BUCHNER AM, Schneider Y, Lichtenstein GR
    Biosimilars in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020 Oct 27. doi: 10.14309/ajg.0000000000000844.
    PubMed     Abstract available


  109. GUBATAN J, Nielsen OH, Levitte S, Juhl CB, et al
    Biologics During Pregnancy in Women With Inflammatory Bowel Disease and Risk of Infantile Infections: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000910.
    PubMed     Abstract available


  110. KHAN N, Patel D, Xie D, Pernes T, et al
    Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001012.
    PubMed     Abstract available


  111. ELTEN M, Benchimol EI, Fell DB, Kuenzig ME, et al
    Residential Greenspace in Childhood Reduces Risk of Pediatric Inflammatory Bowel Disease: A Population-Based Cohort Study.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000990.
    PubMed     Abstract available


  112. FIORINO G, Gilardi D, Radice S, Furfaro F, et al
    Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures.
    Am J Gastroenterol. 2020;115:1719-1721.
    PubMed     Abstract available


  113. MANSOOR E, Khoudari G, Abou Saleh M, Elfadawy N, et al
    The Many Faces of COVID-19: Atypical Presentation of COVID-19 in a Patient With Crohn's Disease With Acute Diarrhea Leading to Severe Hypovolemic Hyponatremia-A Case Report.
    Am J Gastroenterol. 2020;115:1730-1731.
    PubMed    


  114. GIESE-KIM N, Wu M, Dehghan M, Sceats LA, et al
    Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost Savings in Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2020;115:1698-1706.
    PubMed     Abstract available


    September 2020
  115. CHAPARRO M, Gordillo J, Domenech E, Esteve M, et al
    Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000926.
    PubMed     Abstract available


  116. BANTY A, Melmed GY
    Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection?
    Am J Gastroenterol. 2020 Sep 25. doi: 10.14309/ajg.0000000000000921.
    PubMed     Abstract available


  117. SHAFFER SR, Huang E, Patel S, Rubin DT, et al
    Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis.
    Am J Gastroenterol. 2020 Sep 16. doi: 10.14309/ajg.0000000000000847.
    PubMed     Abstract available


  118. LONG MD
    Shining a Light on Skin Cancer in Inflammatory Bowel Disease: A Role for Prevention.
    Am J Gastroenterol. 2020 Sep 11. doi: 10.14309/ajg.0000000000000775.
    PubMed     Abstract available


  119. KAMAL N, Bookwalter A, Foss R, Cross RK, et al
    Pyostomatitis Vegetans: An Unusual Oral Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020;115:1385.
    PubMed    


  120. DALAL RS, Palchaudhuri S, Snider CK, Gitelman Y, et al
    A Multimodal Intervention Using Nonopioid Analgesics Is Associated With Reduced Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2020;115:1474-1485.
    PubMed     Abstract available


  121. QUINN KP, Raffals LE
    An Update on the Medical Management of Inflammatory Pouch Complications.
    Am J Gastroenterol. 2020;115:1439-1450.
    PubMed     Abstract available


    August 2020
  122. LICHTENSTEIN GR, Rubin DT
    Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.
    Am J Gastroenterol. 2020 Aug 24. doi: 10.14309/ajg.0000000000000817.
    PubMed    


  123. COHEN BL, Hanauer SB
    Executive Summary of 'Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States'.
    Am J Gastroenterol. 2020 Aug 20. doi: 10.14309/ajg.0000000000000809.
    PubMed    


  124. PAPA A, Gasbarrini A, Tursi A
    Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020 Aug 19. doi: 10.14309/ajg.0000000000000830.
    PubMed     Abstract available


  125. RAPHAEL KL, Trindade AJ, Zimmerman HM, Sultan KS, et al
    Endoscopic Evaluation of Inflammatory Bowel Disease With High-Grade Dysplasia Should Not Be Delayed During the COVID-19 Pandemic: A Case Report.
    Am J Gastroenterol. 2020 Aug 19. doi: 10.14309/ajg.0000000000000813.
    PubMed    


  126. BERNSTEIN CN, Walld R, Marrie RA
    Social Determinants of Outcomes in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020 Aug 5. doi: 10.14309/ajg.0000000000000794.
    PubMed     Abstract available


  127. WOLF DC, Wolf CH, Rubin DT
    Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
    Am J Gastroenterol. 2020;115:1298.
    PubMed    


  128. NARULA N, Wong ECL, Aruljothy A, Dulai PS, et al
    Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial.
    Am J Gastroenterol. 2020;115:1236-1245.
    PubMed     Abstract available


    July 2020
  129. LITTLE DHW, Tabatabavakili S, Shaffer SR, Nguyen GC, et al
    Effectiveness of Dose De-escalation of Biologic Therapy in Inflammatory Bowel Disease: A Systematic Review.
    Am J Gastroenterol. 2020 Jul 27. doi: 10.14309/ajg.0000000000000783.
    PubMed     Abstract available


  130. BHAT S, Farraye FA, Moss AC
    Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic.
    Am J Gastroenterol. 2020 Jul 20. doi: 10.14309/ajg.0000000000000787.
    PubMed     Abstract available


  131. HAMMOUDI N, Auzolle C, Tran Minh ML, Boschetti G, et al
    Postoperative Endoscopic Recurrence on the Neoterminal Ileum But Not on the Anastomosis Is Mainly Driving Long-Term Outcomes in Crohn's Disease.
    Am J Gastroenterol. 2020;115:1084-1093.
    PubMed     Abstract available


    June 2020
  132. CALDERA F, Hayney MS, Farraye FA
    Vaccination in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020 Jun 10. doi: 10.14309/ajg.0000000000000713.
    PubMed    


  133. YANG DH, Park SJ, Kim HS
    Response to Singh et al.
    Am J Gastroenterol. 2020;115:959-960.
    PubMed    


  134. SINGH A, Narayan J, Behera MK, Mishra D, et al
    High-Definition Chromoendoscopy Was Not Superior to High-Definition White Light Endoscopy in Detecting Colitis-Associated Dysplasia, or Was It?
    Am J Gastroenterol. 2020;115:958-959.
    PubMed    


  135. ROZICH JJ, Holmer A, Singh S
    Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2020;115:832-840.
    PubMed     Abstract available


    May 2020
  136. VASSEUR P, Dugelay E, Benamouzig R, Savoye G, et al
    Dietary Zinc Intake and Inflammatory Bowel Disease in the French NutriNet-Sante Cohort.
    Am J Gastroenterol. 2020 May 27. doi: 10.14309/ajg.0000000000000688.
    PubMed     Abstract available


  137. KHAN N, Patel D, Trivedi C, Kavani H, et al
    Repeated Occurrences of Basal Cell Cancer in Patients With Inflammatory Bowel Disease Treated With Immunosuppressive Medications.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000679.
    PubMed     Abstract available


  138. DULAI PS, Battat R, Barsky M, Nguyen NH, et al
    Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors.
    Am J Gastroenterol. 2020 May 7. doi: 10.14309/ajg.0000000000000596.
    PubMed     Abstract available


  139. SANDS BE, Feagan BG, Sandborn WJ, Schreiber S, et al
    Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 Study.
    Am J Gastroenterol. 2020;115:738-745.
    PubMed     Abstract available


  140. BEWTRA M, Lichtenstein GR
    Mongersen and SMAD-7 Inhibition, Not a Lucky 7 for Patients With IBD: When Trial Design Is as Important as Disease Therapy.
    Am J Gastroenterol. 2020;115:687-688.
    PubMed     Abstract available


  141. LEE MW, Pourmorady JS, Laine L
    Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2020;115:662-670.
    PubMed     Abstract available


    April 2020
  142. MIRANDA E, Meza R, Kolbach M, Torres J, et al
    Sweet Syndrome in Pediatric Active Ulcerative Colitis.
    Am J Gastroenterol. 2020 Apr 27. doi: 10.14309/ajg.0000000000000645.
    PubMed    


  143. LIMDI JK
    Continuing Medical Education Questions: April 2020: Men with Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer.
    Am J Gastroenterol. 2020;115:506.
    PubMed    


  144. GANZLEBEN I, Hirschmann S, Kohler J, Fuchs FS, et al
    Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy.
    Am J Gastroenterol. 2020;115:632-634.
    PubMed    


    March 2020
  145. SHAH A, Macdonald GA, Morrison M, Holtmann G, et al
    Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
    Am J Gastroenterol. 2020 Mar 25. doi: 10.14309/ajg.0000000000000604.
    PubMed     Abstract available


    February 2020
  146. KEDIA S, Mouli VP, Kamat N, Sankar J, et al
    Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2020 Feb 6. doi: 10.14309/ajg.0000000000000527.
    PubMed     Abstract available


  147. HAMMAMI MB, Mahadevan U
    Men With Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer.
    Am J Gastroenterol. 2020 Feb 4. doi: 10.14309/ajg.0000000000000515.
    PubMed     Abstract available


    January 2020
  148. TARGOWNIK LE, Kaplan GG, Witt J, Bernstein CN, et al
    Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.
    Am J Gastroenterol. 2020;115:128-137.
    PubMed     Abstract available


    December 2019
  149. CHATEAU T, Feakins R, Marchal-Bressenot A, Magro F, et al
    Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure.
    Am J Gastroenterol. 2019 Dec 5. doi: 10.14309/ajg.0000000000000437.
    PubMed     Abstract available


    November 2019
  150. CAZZAGON N, Lemoinne S, El Mouhadi S, Trivedi PJ, et al
    The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Nov 14. doi: 10.14309/ajg.0000000000000461.
    PubMed     Abstract available


  151. LEI DK, Ollech JE, Andersen M, Weisshof R, et al
    Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
    Am J Gastroenterol. 2019 Nov 7. doi: 10.14309/ajg.0000000000000460.
    PubMed     Abstract available


  152. AGRAWAL S, Khanna U, Fernandez AP, Irfan M, et al
    Linear Immunoglobulin A Bullous Dermatosis Associated With Ulcerative Colitis.
    Am J Gastroenterol. 2019 Nov 6. doi: 10.14309/ajg.0000000000000449.
    PubMed    


  153. BOOTH AT, Forster E, Curran T, George V, et al
    Gastrocolic Fistula Involving the Pancreas in a Patient With Crohn's Disease.
    Am J Gastroenterol. 2019;114:1823-1824.
    PubMed    


    October 2019
  154. VISCIDO A, Latella G, Frieri G
    Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis.
    Am J Gastroenterol. 2019 Oct 14. doi: 10.14309/ajg.0000000000000427.
    PubMed    


  155. YANG DH, Park SJ, Kim HS, Park YS, et al
    High-Definition Chromoendoscopy Versus High-Definition White Light Colonoscopy for Neoplasia Surveillance in Ulcerative Colitis: A Randomized Controlled Trial.
    Am J Gastroenterol. 2019;114:1642-1648.
    PubMed     Abstract available


    September 2019
  156. WALLENHORST T, Jacques J, Bouguen G, Pagenault M, et al
    Successful Closure of a Rectal Fistula of Crohn's Disease Using Endoscopic Submucosal Dissection Combined With an Over-the-Scope Clip.
    Am J Gastroenterol. 2019;114:1416.
    PubMed    


    August 2019
  157. GREUTER T, Vavricka SR, Scharl M
    Response to Al Sulais et al.
    Am J Gastroenterol. 2019;114:1346-1347.
    PubMed    


  158. AL SULAIS E, AlAmeel T
    Family History Is a Risk Factor for Developing Malignancies.
    Am J Gastroenterol. 2019;114:1346.
    PubMed    


  159. SIMSEK M, de Boer NKH
    Mesalazine and Nephrolithiasis: Leave No Stone Unturned.
    Am J Gastroenterol. 2019;114:1359-1360.
    PubMed    


  160. LU C, Holubar SD, Rieder F
    How I Approach the Management of Stricturing Crohn's Disease.
    Am J Gastroenterol. 2019;114:1181-1184.
    PubMed    


    July 2019
  161. BAR-GIL SHITRIT A, Ben Ya'acov A, Livovsky DM, Cuker T, et al
    Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study.
    Am J Gastroenterol. 2019;114:1172-1175.
    PubMed     Abstract available


  162. BRAUN T, Di Segni A, BenShoshan M, Neuman S, et al
    Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease Flares.
    Am J Gastroenterol. 2019;114:1142-1151.
    PubMed     Abstract available


  163. BISHNOI A, Kaushik A, Banerjee N, Nada R, et al
    Asymptomatic Macrocheilia in an Adult Woman.
    Am J Gastroenterol. 2019;114:1022.
    PubMed    


    May 2019
  164. LICHTENSTEIN GR, Loftus EV, Isaacs KL, Regueiro MD, et al
    Response to Chapman and Jones.
    Am J Gastroenterol. 2019;114:828.
    PubMed    


  165. LICHTENSTEIN GR, Loftus EV, Isaacs KL, Regueiro MD, et al
    Response to Ribaldone.
    Am J Gastroenterol. 2019;114:826-827.
    PubMed    


  166. CHAPMAN BJ, Jones GB
    Underscoring the Biochemical Overlap Between Crohn's Disease and Depression.
    Am J Gastroenterol. 2019;114:827-828.
    PubMed    


  167. RIBALDONE DG
    ACG Clinical Guideline on Crohn's Disease: A Point of View from Europe.
    Am J Gastroenterol. 2019;114:826.
    PubMed    


  168. WU J, Lubman DM, Kugathasan S, Denson LA, et al
    Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease.
    Am J Gastroenterol. 2019;114:777-785.
    PubMed     Abstract available


    April 2019
  169. JAIN A, Nguyen NH, Proudfoot JA, Martin CF, et al
    Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2019;114:630-639.
    PubMed     Abstract available


    March 2019
  170. SINGH S, Jairath V
    Response to Gupta and Hanauer.
    Am J Gastroenterol. 2019;114:535-536.
    PubMed    


  171. HE Y, Zhu Z, Chen Y, Chen F, et al
    Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study.
    Am J Gastroenterol. 2019;114:490-499.
    PubMed     Abstract available


  172. GUPTA N, Hanauer SB
    Too Soon to Discard 5-ASAs?
    Am J Gastroenterol. 2019;114:534-535.
    PubMed    


    February 2019
  173. FRIEDMAN S, Norgard BM
    Response to Zhao et al.
    Am J Gastroenterol. 2019;114:358-359.
    PubMed    


  174. BERENBLUM C
    An Issue of Control: Patient Perspectives on Use of Nutritional Interventions for IBD.
    Am J Gastroenterol. 2019;114:192-193.
    PubMed    


    January 2019
  175. LICHTENSTEIN GR, Loftus EV Jr, Isaacs KL, Regueiro MD, et al
    Response to Chamberlin and Borody.
    Am J Gastroenterol. 2019;114:171-174.
    PubMed    


  176. CHAMBERLIN W, Borody T
    Comment on 2018 ACG Clinical Guideline: Antibiotics in Crohn's Disease.
    Am J Gastroenterol. 2019;114:170-171.
    PubMed    


  177. SAEZ-GONZALEZ E, Salavert M, Cerrillo E, Moret I, et al
    Secondary Haemophagocytic Syndrome and Overlapping Immune Reconstitution Syndrome: Life-Threatening Complications of Anti-TNF-alpha Treatment for Crohn's Disease.
    Am J Gastroenterol. 2019;114:177-179.
    PubMed    


  178. LIU PH, Lebwohl B, Burke KE, Ivey KL, et al
    Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women without Celiac Disease: A Prospective Cohort Study.
    Am J Gastroenterol. 2019;114:127-134.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: